23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Orange</strong> <strong>Guide</strong> – Chapter 2: Detailing to HCPs<br />

business <strong>and</strong> legal risks if not done in the appropriate manner. Further, when working with employers,<br />

you should treat their employees as consumers, <strong>and</strong> your discussions should follow <strong>Pfizer</strong>’s guidance on<br />

interactions with consumers. See <strong>Orange</strong> <strong>Guide</strong> Chapter 16: Consumer <strong>and</strong> Employee Interactions for<br />

guidance on interactions with consumers <strong>and</strong> employees.<br />

In working with employers, you may interact with medical personnel such as on-site HCPs, <strong>and</strong> non-<br />

medical personnel such as CEOs, CFOs, CMDs, benefit managers, <strong>and</strong> brokers/consultants. These<br />

employer representatives often have influence over the products to which employees have access <strong>and</strong><br />

over the coverage levels provided by their health benefit plans. When communicating with individuals<br />

such as employer representatives or benefits brokers, you must speak with them as you would speak<br />

with HCPs (as opposed to consumers). As with other HCPs, you must always give a fair <strong>and</strong> balanced<br />

presentation that includes both the benefits <strong>and</strong> risks of the product. You should treat all employer<br />

representatives <strong>and</strong> benefits professionals as if they are subject to federal <strong>and</strong> state healthcare laws,<br />

including anti-kickback laws, even if they may not participate in government programs.<br />

When interacting with employer representatives <strong>and</strong> benefits professionals, you should tailor any<br />

product discussion carefully to their background, especially if they do not have a medical background.<br />

Use appropriate, RC-approved, employer market specific tools since resources that are designed for<br />

other audiences may not resonate with or be appropriate for these customers.<br />

Benefits professionals may want to discuss the coverage offerings <strong>and</strong> access opportunities for <strong>Pfizer</strong><br />

products. You may engage in discussions about access for <strong>Pfizer</strong> products, provided that your<br />

statements are truthful, accurate, not misleading, <strong>and</strong> provided that you only use RC-approved<br />

materials, such as approved access grids. You may not direct employers to a specific PBM/HMO or<br />

encourage an employer to switch to a different PBM/HMO. The rebate agreement terms we have with<br />

customers (including PBMs <strong>and</strong> HMOs) are confidential (as is the existence of the rebate agreement<br />

itself) <strong>and</strong> must never be discussed with employers, even when the terms are related to the PBM/HMO<br />

of that employer. Directing or influencing employers to work with a specific broker or consultant is also<br />

prohibited.<br />

To best leverage existing relationships <strong>and</strong> avoid providing inconsistent messages, you must inform the<br />

National Director Employer (NDE) or other appropriate CGC representative in your region about your<br />

activities with employers <strong>and</strong> coordinate with such persons as needed. NDEs are colleagues who are<br />

dedicated to working with employer groups <strong>and</strong> benefits professionals. NDEs collaborate directly with<br />

32<br />

Rev. 09/12<br />

Page 17 of 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!